carboplatin · Corden Pharma · NDA 019880, 020452

Paraplatin

Earliest generic entry, as listed · earliest of 7 marketed strengths
Open now

No marketed reference-listed strength; date taken from all listed strengths.

No unexpired patents or exclusivities are listed for this product.

Listed patents · 0 unexpired

No unexpired patents listed.

Exclusivities · 0 unexpired

No unexpired exclusivities listed.

Paragraph IV certifications · 0

No Paragraph IV certification listed by FDA for this drug.

The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.

Event history

  • Generic approved · ANDA 219999, Qilu Pharm Hainan · 020452-001Approved 4 Feb 2026Detected 25 Oct 2026Historical import

Products covered · 7

NDA · productFormStrengthListed expiry
019880 · 001 · RLD · discontinuedinjectable, injection50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
019880 · 002 · RLD · discontinuedinjectable, injection150MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
019880 · 003 · RLD · discontinuedinjectable, injection450MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
020452 · 001 · RLD · discontinuedinjectable, intravenous50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
020452 · 002 · RLD · discontinuedinjectable, intravenous150MG/15ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
020452 · 003 · RLD · discontinuedinjectable, intravenous450MG/45ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open
020452 · 004 · RLD · discontinuedinjectable, intravenous600MG/60ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**open